Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Germing

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Leukemia & Lymphoma|September 14, 2004
Risk assessment in chronic myelomonocytic leukemia (CMML)U Germing, A Kündgen, N Gattermann
International Journal of Hematology|August 16, 2001
Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statisticsC Aul, A Giagounidis, U Germing
Leukemia|June 13, 2008
Improving the prognostic evaluation of patients with lower risk myelodysplastic syndromesA Kuendgen, N Gattermann, U Germing
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|February 3, 2005
[Splenectomy for thrombocytopenic purpura. Retrospective analysis of the postoperative course]K Beseoglu, U Germing, W Gross-Weege
Leukemia Research|January 4, 2001
Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphomaE Misgeld, U Germing, C Aul, et al.
Annals of Hematology|October 10, 2002
Evaluating the prognosis of patients with myelodysplastic syndromesC Aul, A Giagounidis, U Germing, et al.
Deutsche Medizinische Wochenschrift (1946)|January 27, 2012
[Myelodysplastic syndromes (MDS)]U Germing, A Kündgen, R Haas, et al.
British Journal of Haematology|June 25, 2025
Clinical management of CMML-State of the artK Nachtkamp, F Schulz, N Gattermann, et al.
Leukemia Research|May 19, 1998
Increasing incidence of myelodysplastic syndromes: real or fictitious?C Aul, U Germing, N Gattermann, et al.
Der Radiologe|September 28, 2000
[Bone marrow involvement in hematologic neoplasms and solid tumors]S Martin, U Germing, R Kronenwett, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|September 14, 2004
Risk assessment in chronic myelomonocytic leukemia (CMML)U Germing, A Kündgen, N Gattermann
International Journal of Hematology|August 16, 2001
Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statisticsC Aul, A Giagounidis, U Germing
Leukemia|June 13, 2008
Improving the prognostic evaluation of patients with lower risk myelodysplastic syndromesA Kuendgen, N Gattermann, U Germing
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|February 3, 2005
[Splenectomy for thrombocytopenic purpura. Retrospective analysis of the postoperative course]K Beseoglu, U Germing, W Gross-Weege
Leukemia Research|January 4, 2001
Secondary myelodysplastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphomaE Misgeld, U Germing, C Aul, et al.
Annals of Hematology|October 10, 2002
Evaluating the prognosis of patients with myelodysplastic syndromesC Aul, A Giagounidis, U Germing, et al.
Deutsche Medizinische Wochenschrift (1946)|January 27, 2012
[Myelodysplastic syndromes (MDS)]U Germing, A Kündgen, R Haas, et al.
British Journal of Haematology|June 25, 2025
Clinical management of CMML-State of the artK Nachtkamp, F Schulz, N Gattermann, et al.
Leukemia Research|May 19, 1998
Increasing incidence of myelodysplastic syndromes: real or fictitious?C Aul, U Germing, N Gattermann, et al.
Der Radiologe|September 28, 2000
[Bone marrow involvement in hematologic neoplasms and solid tumors]S Martin, U Germing, R Kronenwett, et al.
Pageof 13